Since breast cancer tissues often express the HER2 molecule to some extent, even if the diagnosis is not of a HER2 3 + type, we examined both the cross-reactivity to CH401MAP in BC or PBS-immunized BC-M plasma as well as the HER2 expression levels (Fig. S8 in the Supplementary material). Here, ERBB2 is linked to breast carcinoma.